EP0452598A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of a polypeptide having interleukin-2 activity for the preparation of a pharmaceutical composition for the treatment of simple pleura cancer
Assignee: Aventis Pharma SA
•
Filing: 1990-06-06
•
Granted: —
•
Expires: 2010-06-06
Abstract
Abstract The use of a polypeptide (I) with human interleukin 2 activity is claimed for treating primary cancers of the pleura, especially mesothelioma. Pref. (I) is a pure recombinant IL-2, especially in the non-glycosylated reduced form.
Inventors
- 👤 Maud Brandely
- 👤 Danielle Lando
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-06 13:19
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/20; A61K38/2013; A61P; A61P35/00
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
EP0353150A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.